glp-1 and parkinson's disease drug may help with disease, study reports GLP-1 and the Degenerating Brain:

These agents also have substantial protective effects on cognitive and behavioral functions, such as motor function

The antibodies used in WB were: INSULIN (1:1000, ab181547, Abcam), PPAR (1:1000, 74076 S, CST), UCP2 (1:1000, 89326 S, CST), PDX1 (1:1000, ab219207, Abcam), MAFA (1:1000, 7937 S, CST), IRS1 (1:1000, 2390 S, CST), GCK (1:1000, 19666-1-AP, Proteintech), -ACTIN (1:1000, PM053, MBL) and -TUBULIN (1:1000, 2128 S, CST)

doi: 10.1016/j.biopha.2021.111778 [DOI] [PubMed] [Google Scholar] 134

If symptoms are severe, eating smaller, more frequent meals rather than large portions can reduce the burden on your digestive system whilst it adjusts to the GLP-1 medication

$200+ in-person) but doesn't change the drug price itself

Going up in dose too fast is a frequent reason people feel worse than necessary